Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140634 · ClinicalTrials.gov registry record
The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients
A clinical trial, sponsored by Vericel Corporation.
- Completed
- Registry status
- 2,233
- Enrollment target
NCT00140634: Completed study, sponsored by Vericel Corporation.
NCT00140634 is a clinical trial that has completed, run by Vericel Corporation. The registered enrollment target is 2,233 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00140634 has completed, sponsored by Vericel Corporation.
- COMPLETED
- Registry status
- 2,233 participants
- Enrollment target
Study Summary
The objectives of the Cartilage Repair Registry is to report the long term efficacy and safety of cartilage repair procedures in Registry patients.
Primary Outcome
Overall assessment of the patient by the physician based on knee examination and progress of rehabilitation
Interventions
- BIOLOGICAL Carticel (autologous cultured chondrocyte) implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,233 participants |
| Start Date | 1995-03 |
| Est. Completion | 2009-01 |
What the finished NCT00140634 record still lists
NCT00140634 is an observational study that tracks outcomes without assigning an intervention. Its 2,233 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Carticel (autologous cultured chondrocyte) implantation is the first listed.
NCT00140634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00140634 about?
NCT00140634 is a clinical study titled "The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients". The objectives of the Cartilage Repair Registry is to report the long term efficacy and safety of cartilage repair procedures in Registry patients.
What is the current status of trial NCT00140634?
This trial is currently completed. The enrollment target is 2,233 participants. The study started on 1995-03. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00140634?
The interventions under investigation include: Carticel (autologous cultured chondrocyte) implantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00140634?
This trial is sponsored by Vericel Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia